Gene Therapy to Treat Aortic Aneurysms
- 16 August 2005
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (7) , 939-940
- https://doi.org/10.1161/circulationaha.105.558767
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Overexpression of Transforming Growth Factor-β1 Stabilizes Already-Formed Aortic AneurysmsCirculation, 2005
- A Randomized Trial Comparing Conventional and Endovascular Repair of Abdominal Aortic AneurysmsNew England Journal of Medicine, 2004
- Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysmsJournal of Vascular Surgery, 2004
- Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the united states during 2001Journal of Vascular Surgery, 2004
- Vascular Smooth Muscle Cell Endovascular Therapy Stabilizes Already Developed Aneurysms in a Model of Aortic Injury Elicited by Inflammation and ProteolysisAnnals of Surgery, 2004
- Paracrine secretion of transforming growth factor-β1 in aneurysm healing and stabilization with endovascular smooth muscle cell therapy1 1Competition of interest: none.Journal of Vascular Surgery, 2003
- Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysmsJournal of Clinical Investigation, 2000
- Pharmacologic suppression of experimental abdominal aortic aneurysms: A comparison of doxycycline and four chemically modified tetracyclinesJournal of Vascular Surgery, 1998
- Prevalence and Associations of Abdominal Aortic Aneurysm Detected through ScreeningAnnals of Internal Medicine, 1997
- Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activityJournal of Vascular Surgery, 1995